Home > Healthcare > U.S. Vitrification Market > Table of Contents

U.S. Vitrification Market – By Product Type (Devices [Open System, Closed System], Kits, Reagents), Specimen (Embryos, Oocytes, Sperms), End-user (IVF Clinics, Biobanks), Zone – Forecast 2024 ­ 2032

  • Report ID: GMI10251
  • Published Date: Jul 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definitions

1.2    Research design

1.2.1    Research approach

1.2.2    Data collection methods

1.3    Base estimates & calculations

1.3.1    Base year calculation

1.3.2    Key trends for market estimation

1.4    Forecast model

1.5    Primary research and validation

1.5.1    Primary sources

1.5.2    Data mining sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    Increasing demand for fertility treatment

3.2.1.2    Expanding biobanking sector

3.2.1.3    Rising awareness and acceptance of IVF

3.2.1.4    Advancements in cryopreservation technologies

3.2.2    Industry pitfalls & challenges

3.2.2.1    High cost of vitrification procedure

3.2.2.2    Stringent regulatory requirements

3.3    Growth potential analysis

3.4    Regulatory landscape

3.5    Technology landscape

3.6    Porter’s analysis

3.7    PESTEL analysis

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company market share analysis

4.3    Company matrix analysis

4.4    Competitive analysis of major market players

4.5    Competitive positioning matrix

4.6    Strategic dashboard

Chapter 5   Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

5.1    Key trends

5.2    Devices

5.2.1    Open system

5.2.2    Closed system

5.3    Kits

5.4    Reagents & consumables

Chapter 6   Market Estimates and Forecast, By Specimen, 2021 - 2032 ($ Mn)

6.1    Key trends

6.2    Embryos

6.3    Oocytes

6.4    Sperms

Chapter 7   Market Estimates and Forecast, By End-user, 2021 - 2032 ($ Mn)

7.1    Key trends

7.2    In vitro fertilization clinics

7.3    Biobanks

Chapter 8   Market Estimates and Forecast, By Zone, 2021 - 2032 ($ Mn)

8.1    Key trends

8.2    Northeast

8.2.1    Connecticut

8.2.2    Maine

8.2.3    Massachusetts

8.2.4    New Hampshire

8.2.5    Rhode Island

8.2.6    Vermont

8.2.7    New Jersey

8.2.8    New York

8.2.9    Pennsylvania

8.3    East North Central

8.3.1    Wisconsin

8.3.2    Michigan

8.3.3    Illinois

8.3.4    Indiana

8.3.5    Ohio

8.4    West North Central

8.4.1    North Dakota

8.4.2    South Dakota

8.4.3    Nebraska

8.4.4    Kansas

8.4.5    Minnesota

8.4.6    Iowa

8.4.7    Missouri

8.5    South Atlantic

8.5.1    Delaware

8.5.2    Maryland

8.5.3    Virginia

8.5.4    West Virginia

8.5.5    North Carolina

8.5.6    South Carolina

8.5.7    Georgia

8.5.8    Florida

8.6    East South Central

8.6.1    Kentucky

8.6.2    Tennessee

8.6.3    Mississippi

8.6.4    Alabama

8.7    West South Central

8.7.1    Oklahoma

8.7.2    Texas

8.7.3    Arkansas

8.7.4    Louisiana

8.8    Mountain States

8.8.1    Idaho

8.8.2    Montana

8.8.3    Wyoming

8.8.4    Nevada

8.8.5    Utah

8.8.6    Colorado

8.8.7    Arizona

8.8.8    New Mexico

8.9    Pacific Central

8.9.1    California

8.9.2    Alaska

8.9.3    Hawaii

8.9.4    Oregon

8.9.5    Washington

Chapter 9   Company Profiles

9.1    Biotech, Inc.

9.2    CooperSurgical Fertility Company

9.3    FERTIPRO NV

9.4    FUJIFILM Irvine Scientific

9.5    Genea BIOMEDX

9.6    IMV Technologies Group (Cryo Bio System)

9.7    Kitazato Corporation.

9.8    MFC Global

9.9    MINITÜB GMBH

9.10    NidaCon International AB

9.11    Optimas

9.12    Shenzhen VitaVitro Biotech

9.13    Vitrolife
 

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 13
  • Tables & Figures: 504
  • Countries covered: 1
  • Pages: 160
 Download Free Sample